• HOME
    KOREAN
    CHINESS
    SITE MAP
    JOIN
  • Username (Site Login ID)
  • Password
  • Forgot your password?

  • ½É¸®Àûµµ¹Ú | Cases and Studies in Pathological Gambling | êý戏设计

    date : 2015-05-20 01:10|hit : 2068
    Article] DSM-IV pathological gambling in the National Comorbidity Survey Replication
    DocNo of ILP: 3667

    Doc. Type: Article

    Title: DSM-IV pathological gambling in the National Comorbidity Survey Replication

    Authors: Kessler, RC; Hwang, I; LaBrie, R; Petukhova, M; Sampson, NA; Winters, KC; Shaffer, HJ

    Full Name of Authors: Kessler, R. C.; Hwang, I.; LaBrie, R.; Petukhova, M.; Sampson, N. A.; Winters, K. C.; Shaffer, H. J.

    Keywords by Author: epidemiology; National Comorbidity Survey Replication (NCS-R); pathological gambling

    Keywords Plus: WORLD-HEALTH-ORGANIZATION; PSYCHIATRIC-DISORDERS; TEMPORAL PROGRESSION; DEPENDENCE SYMPTOMS; UNITED-STATES; NCS-R; PREVALENCE; ALCOHOL; DIAGNOSES; LIFETIME

    Abstract: Background. Little is known about the prevalence or correlates of DSM-IV pathological gambling (PG). Method. Data from the US National Comorbidity Survey Replication (NCS-R), a nationally representative US household survey, were used to assess lifetime gambling symptoms and PG along with other DSM-IV disorders. Age of onset (AOO) of each lifetime disorder was assessed retrospectively. AOO reports were used to study associations between temporally primary disorders and the subsequent risk of secondary disorders. Results. Most respondents (78.4%) reported lifetime gambling. Lifetime problem gambling (at least one Criterion A symptom of PG) (2.3%) and PG (0.6%) were much less common. PG was significantly associated with being young, male, and Non-Hispanic Black. People with PG reported first gambling significantly earlier than non-problem gamblers (mean age 16.7 nu. 23.9 years, z = 12.7, p < 0.001), with gambling problems typically beginning during the mid-20s and persisting for an average of 9.4 years. During this time the largest annual gambling losses averaged US$4800. Onset and persistence of PG were predicted by a variety of prior DSM-IV anxiety, mood, impulse-control and substance use disorders. PG also predicted the subsequent onset of generalized anxiety disorder, post-traumatic stress disorder (PTSD) and substance dependence. Although none of the NCS-R respondents with PG ever received treatment for gambling problems, 49.0%, were treated at some time for other mental disorders. Conclusions. DSM-IV PG is a comparatively rare, seriously impairing, and undertreated disorder whose symptoms typically start during early adulthood and is frequently secondary to other mental or substance disorders that are associated with both PG onset and persistence.

    Cate of OECD: Basic medicine

    Year of Publication: 2008

    Business Area: gamble

    Detail Business: gamble

    Country: USA

    Study Area:

    Name of Journal: PSYCHOLOGICAL MEDICINE

    Language: English

    Country of Authors: [Kessler, R. C.; Hwang, I.; Petukhova, M.; Sampson, N. A.] Harvard Univ, Dept Hlth Care Policy, Sch Med, Boston, MA 02115 USA; [LaBrie, R.; Shaffer, H. J.] Cambridge Hlth Alliance, Div Addict, Boston, MA USA; [Winters, K. C.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA

    Press Adress: Kessler, RC (reprint author), Harvard Univ, Dept Hlth Care Policy, Sch Med, 180 Longwood Ave, Boston, MA 02115 USA.

    Email Address: kessler@hcp.med.harvard.edu

    Citaion:

    Funding: National Institute of Mental Health (NIMH) [U01-MH60220]; National Institute on Drug Abuse (NIDA); Substance Abuse and Mental Health Services Administration (SAMHSA); Robert Wood Johnson Foundation (RWJF) [044708]; John W. Alden Trust; National Center for Responsible Gaming; NIMH [R01 MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R01-TW006481]; Pan American Health Organization; Bristol-Myers Squibb; Eli Lilly and Company; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Pfizer

    Lists of Citation: American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Angst J, 2000, COMPR PSYCHIAT, V41, P39, DOI 10.1016/S0010-440X(00)80007-3; [Anonymous], 1994, DIAGN STAT MAN MENT; BLAND RC, 1993, CAN J PSYCHIAT, V38, P108; Cunningham-Williams RM, 1998, AM J PUBLIC HEALTH, V88, P1093, DOI 10.2105/AJPH.88.7.1093; Cunningham-Williams R M, 2000, J Gambl Stud, V16, P347; Cunningham-Williams RM, 2005, J PSYCHIAT RES, V39, P377, DOI 10.1016/j.jpsychires.2004.09.002; First M. B., 2002, STRUCTURED CLIN INTE; Halli SS, 1992, ADV TECHNIQUES POPUL; KALLICK M, 1979, SURVEY AM GAMBLING A; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.279; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; Knauper B, 1999, INT J METH PSYCH RES, V8, P39, DOI DOI 10.1002/MPR.55; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P604, DOI 10.1001/archpsyc.63.6.604; LADOUCEUR R, 1991, CAN J PSYCHIAT, V36, P732; National Research Council, 1999, PATH GAMBL CRIT REV; Nelson CB, 1998, J CONSULT CLIN PSYCH, V66, P474, DOI 10.1037//0022-006X.66.3.474; Petry NM, 2005, J CLIN PSYCHIAT, V66, P564; Research Triangle Institute, 2002, SUDAAN PROF SOFTW SU; Scherrer JF, 2007, ADDICTION, V102, P970, DOI 10.1111/j.1360-0443.2007.01833.x; Shaffer HJ, 2002, ADDICTION, V97, P543, DOI 10.1046/j.1360-0443.2002.00114.x; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; SIMON GE, 1995, EPIDEMIOL REV, V17, P221; Specker S M, 1996, J Gambl Stud, V12, P67, DOI 10.1007/BF01533190; VOLBERG RA, 1994, AM J PUBLIC HEALTH, V84, P237, DOI 10.2105/AJPH.84.2.237; Welte J, 2001, J STUD ALCOHOL, V62, P706; WILLETT JB, 1997, TRAJECTORIES TURNING, P273; Wolter KM, 1985, INTRO VARIANCE ESTIM; World Health Organization, 1991, INT CLASS DIS ICD 10

    Number of Citaion: 32

    Publication: CAMBRIDGE UNIV PRESS

    City of Publication: NEW YORK

    Address of Publication: 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA

    ISSN: 0033-2917

    29-Character Source Abbreviation: PSYCHOL MED

    ISO Source Abbreviation: Psychol. Med.

    Volume: 38

    Version: 9

    Start of File: 1351

    End of File: 1360

    DOI: 10.1017/S0033291708002900

    Number of Pages: 10

    Web of Science Category: Psychology, Clinical; Psychiatry; Psychology

    Subject Category: Psychology; Psychiatry

    Document Delivery Number: 344FF

    Unique Article Identifier: WOS:000258911400014

    [ÀÌ °Ô½Ã¹°Àº HyeJung Mo¡¦´Ô¿¡ ÀÇÇØ 2015-05-20 15:31:15 GAMBLING¿¡¼­ À̵¿ µÊ]
    reply : 0
  • list
  • prev
  • next